PhenomeX’s Beacon® Technology Enables Early Identification of Potent Omicron-Neutralizing Antibodies

EMERYVILLE, Calif., June 13, 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced that the Company’s technology was recently featured in a groundbreaking study published in Cell Reports titled “Potent Omicron-neutralizing antibodies…